ConductScience.org, home

Paper28298083

Alpha-Synuclein Disease Mutations Are Structurally Defective and Locally Affect Membrane Binding.

Robotta M and 4 others. J Am Chem Soc, 2017. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Alpha-Synuclein Disease Mutations Are Structurally Defective and Locally Affect Membrane Binding. Papers, record 28298083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28298083

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alpha-Synuclein Disease Mutations Are Structurally Defective and Locally Affect Membrane Binding.
PubMed
Journal
J Am Chem Soc
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2018-05-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Robotta MMarta
2Cattani JJulia
3Martins JCJuliana Cristina
4Subramaniam VVinod
5Drescher MMaltehttps://orcid.org/0000-0002-3571-3452

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lipid BilayersMajor topic
Parkinson DiseaseMajor topic
alpha-SynucleinMajor topic
Binding Sites
Electron Spin Resonance Spectroscopy
Humans
Mutation

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
40994307Zn2+ Binding Shifts the Conformational Ensemble of α-Synuclein Monomers toward Accelerated Amyloid Formation.J Am Chem Soc2025https://conductscience.org/library/papers/40994307PubMed
40097723Preclinical assessment of a ganglioside-targeted therapy for Parkinson's disease with the first-in-class adaptive peptide AmyP53.Sci Rep2025https://conductscience.org/library/papers/40097723PubMed
39996490Expanding our understanding of synucleinopathies: proteinopathy, proteinopenia, and lipidopathy.FEBS J2025https://conductscience.org/library/papers/39996490PubMed
38739933The Role of Liquid-Liquid Phase Separation in the Accumulation of Pathological Proteins: New Perspectives on the Mechanism of Neurodegenerative Diseases.Aging Dis2024https://conductscience.org/library/papers/38739933PubMed
36834792Aggregation of Disordered Proteins Associated with Neurodegeneration.Int J Mol Sci2023https://conductscience.org/library/papers/36834792PubMed
36380732α-Synuclein Disrupts Vesicle Fusion by Two Mutant-Specific Mechanisms.Mol Cells2022https://conductscience.org/library/papers/36380732PubMed
36111783Propagation of Parkinson's disease by extracellular vesicle production and secretion.Biochem Soc Trans2022https://conductscience.org/library/papers/36111783PubMed
34733860Alpha-Synuclein Aggregation in Parkinson's Disease.Front Med (Lausanne)2021https://conductscience.org/library/papers/34733860PubMed
34307295α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques.Front Chem2021https://conductscience.org/library/papers/34307295PubMed
34124057"Janus-Faced" α-Synuclein: Role in Parkinson's Disease.Front Cell Dev Biol2021https://conductscience.org/library/papers/34124057PubMed
33663214Intracellular Protein-Lipid Interactions Studied by Rapid-Scan Electron Paramagnetic Resonance Spectroscopy.J Phys Chem Lett2021https://conductscience.org/library/papers/33663214PubMed
32201713The mechanism of Hsp90-induced oligomerizaton of Tau.Sci Adv2020https://conductscience.org/library/papers/32201713PubMed
31728405Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let's talk about the lipids in the room.NPJ Parkinsons Dis2019https://conductscience.org/library/papers/31728405PubMed
31118888Lipids at the Crossroad of α-Synuclein Function and Dysfunction: Biological and Pathological Implications.Front Cell Neurosci2019https://conductscience.org/library/papers/31118888PubMed
29621217Nature Biotechnology's academic spinouts of 2017.Nat Biotechnol2018https://conductscience.org/library/papers/29621217PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
LINC02605112935892PubTator's text mininghttps://conductscience.org/library/genes/112935892NCBI Gene
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28298083

GET https://conductscience.org/api/papers/v1/28298083/authors